Cleerly ISCHEMIA vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly ISCHEMIA and EchoGo Amyloidosis are adjacent cardiology AI tools, as they both leverage AI to assist in cardiac diagnosis but target different conditions and utilize different imaging modalities. Cleerly ISCHEMIA analyzes CCTA scans to detect coronary artery ischemia, while EchoGo Amyloidosis screens echocardiogram video clips for early detection of cardiac amyloidosis. Therefore, the choice between them depends on the specific cardiac pathology being investigated.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. EchoGo Amyloidosis is the first FDA-cleared AI-powered screening tool that analyzes echocardiogram video clips to aid in the early detection of cardiac amyloidosis.
Cleerly ISCHEMIA requires Coronary CT Angiography (CCTA) scans for its analysis. EchoGo Amyloidosis analyzes echocardiogram video clips to identify suspected cardiac amyloidosis.
Cleerly ISCHEMIA provides vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment. EchoGo Amyloidosis provides a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis, based on its analysis of echocardiographic markers like ventricular volume, cardiac function, and myocardial movement.
EchoGo Amyloidosis highlights high diagnostic accuracy with 85% sensitivity and 93% specificity, and consistent performance across cardiac amyloidosis subtypes (AL, wild-type ATTR, variant ATTR). Cleerly ISCHEMIA offers 3D digital models of coronary arteries, comprehensive interactive web-based reports, and integration with PowerScribe via API.
More Comparisons
Backers
Who funded each tool's parent company.